Gilead

Gilead

Gilead Sciences, a research-based biopharmaceutical company, discovers, develops and commercialises innovative medicines in areas of unmet need. Gilead’s primary areas of focus include HIV/AIDS, liver diseases, haematology and cancer, inflammatory and serious respiratory diseases, and cardiovascular conditions. Founded in 1987 in Foster City, California, Gilead now employs more than 7,700 people worldwide. Over 25 years, Gilead has become a leading biopharmaceutical company with a rapidly expanding product portfolio and a growing pipeline of investigational drugs.

View the Symposium Invitation

INDUSTRY SYMPOSIUM
08.30-10.00, Saturday 12 September
Conquering C – leaving no one behind 
Gilead